Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmaceutics
|
September 7, 2016
An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
Dileep R Janagam, Lizhu Wang, Suryatheja Ananthula, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 27, 2015
Development and validation of sensitive LC/MS/MS method for quantitative bioanalysis of levonorgestrel in rat plasma and application to pharmacokinetics study
Suryatheja Ananthula, Dileep R Janagam, Seshulatha Jamalapuram, et al.
European Journal of Medicinal Chemistry
|
January 1, 2013
Optimization of tocotrienols as antiproliferative and antimigratory leads
Fathy A Behery, Mohamed R Akl, Suryatheja Ananthula, et al.
Biofactors (Oxford, England)
|
June 28, 2013
Potential role of tocotrienols in the treatment and prevention of breast cancer
Paul W Sylvester, Mohamed R Akl, Abhita Malaviya, et al.
Advanced Biosystems
|
July 11, 2020
Injectable In Situ Forming Depot Systems for Long-Acting Contraception
Dileep R Janagam, Suryatheja Ananthula, Kamaljit Chaudhry, et al.
Biomed Research International
|
August 21, 2014
δ-Tocotrienol oxazine derivative antagonizes mammary tumor cell compensatory response to CoCl2-induced hypoxia
Suryatheja Ananthula, Parash Parajuli, Fathy A Behery, et al.
Anticancer Research
|
June 13, 2014
Oxazine derivatives of γ- and δ-tocotrienol display enhanced anticancer activity in vivo
Suryatheja Ananthula, Parash Parajuli, Fathy A Behery, et al.
Oncotarget
|
March 19, 2016
Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers
Suryatheja Ananthula, Abhilasha Sinha, Mohamed El Gassim, et al.
The Journal of Allergy and Clinical Immunology
|
April 8, 2023
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury
Suryatheja Ananthula, Kirthiram Krishnaveni Sivakumar, Marco Cardone, et al.
The Journal of Clinical Investigation
|
May 22, 2018
A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity
Marco Cardone, Karla Garcia, Mulualem E Tilahun, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmaceutics
|
September 7, 2016
An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
Dileep R Janagam, Lizhu Wang, Suryatheja Ananthula, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 27, 2015
Development and validation of sensitive LC/MS/MS method for quantitative bioanalysis of levonorgestrel in rat plasma and application to pharmacokinetics study
Suryatheja Ananthula, Dileep R Janagam, Seshulatha Jamalapuram, et al.
European Journal of Medicinal Chemistry
|
January 1, 2013
Optimization of tocotrienols as antiproliferative and antimigratory leads
Fathy A Behery, Mohamed R Akl, Suryatheja Ananthula, et al.
Biofactors (Oxford, England)
|
June 28, 2013
Potential role of tocotrienols in the treatment and prevention of breast cancer
Paul W Sylvester, Mohamed R Akl, Abhita Malaviya, et al.
Advanced Biosystems
|
July 11, 2020
Injectable In Situ Forming Depot Systems for Long-Acting Contraception
Dileep R Janagam, Suryatheja Ananthula, Kamaljit Chaudhry, et al.
Biomed Research International
|
August 21, 2014
δ-Tocotrienol oxazine derivative antagonizes mammary tumor cell compensatory response to CoCl2-induced hypoxia
Suryatheja Ananthula, Parash Parajuli, Fathy A Behery, et al.
Anticancer Research
|
June 13, 2014
Oxazine derivatives of γ- and δ-tocotrienol display enhanced anticancer activity in vivo
Suryatheja Ananthula, Parash Parajuli, Fathy A Behery, et al.
Oncotarget
|
March 19, 2016
Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers
Suryatheja Ananthula, Abhilasha Sinha, Mohamed El Gassim, et al.
The Journal of Allergy and Clinical Immunology
|
April 8, 2023
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury
Suryatheja Ananthula, Kirthiram Krishnaveni Sivakumar, Marco Cardone, et al.
The Journal of Clinical Investigation
|
May 22, 2018
A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity
Marco Cardone, Karla Garcia, Mulualem E Tilahun, et al.
Page
of 2